Study finds one shot of HPV vaccine just as effective as two; cervical cancer screening guidelines updated
A study published Dec. 3 by the New England Journal of Medicine found that one dose of the HPV vaccine could be as effective as two in preventing cervical cancer. The study, led by the National Cancer Institute, consisted of a randomized trial of 20,320 girls ages 12-16. In addition, the American Cancer Society Dec. 4 announced updated guidelines for cervical cancer screening, saying that self-collection of vaginal samples for HPV testing is now optional, although clinician-collected samples are preferred.
Related News Articles
Headline
The Department of Health and Human Services July 22 announced that it will participate in the Genesis Mission, an artificial intelligence initiative focusing…
Headline
Ryane Jackson, vice president of Community Health Network at Memorial Hermann Health System, explains how the system is creating seamless connections between…
Headline
The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be…
Headline
The Centers for Medicare & Medicaid Services April 13 announced that more than 150 organizations have been accepted to participate in the launch of its…
Headline
The AHA and dozens of other organizations April 14 sent a letter of support to Reps. Suzan DelBene, D-Wash., and Mike Kelly, R-Pa., for their introduction…
Headline
The Department of Health and Human Services and Centers for Medicare & Medicaid Services announced members of the Healthcare Advisory Committee March 26.…